Novavax
Trade Novavax 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NVAX
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines.
NVAX Key Statistics
Stock Snapshot
Novavax(NVAX) stock is priced at $7.04, giving the company a market capitalization of 1.14B. It carries a P/E multiple of 3.99.
On 2025-11-14, Novavax(NVAX) stock traded between a low of $6.88 and a high of $7.18. Shares are currently priced at $7.04, which is +2.4% above the low and -1.9% below the high.
Novavax(NVAX) shares are trading with a volume of 1.82M, against a daily average of 4.9M.
In the last year, Novavax(NVAX) shares hit a 52-week high of $11.55 and a 52-week low of $5.01.
In the last year, Novavax(NVAX) shares hit a 52-week high of $11.55 and a 52-week low of $5.01.
NVAX News
B. Riley lowered the firm’s price target on Novavax (NVAX) to $16 from $18 and keeps a Buy rating on the shares following the Q3 report. The firm highlights the...
Novavax (NVAX) made headlines this week after reporting Q3 revenue that surpassed expectations, finalizing the transfer of U.S. marketing rights for its COVID-1...
In November 2025, Novavax completed the transfer of U.S. marketing authorization for its COVID-19 vaccine to Sanofi and reported third quarter results, which in...